Chief Executive Tom Polen said he believes the separation would help differentiate BD in the medical-technology industry, and ...
Luna Bioscience moves ahead with work on a vaccine to prevent a deadly infection that spreads from animals to humans, as ...
19h
Hosted on MSNTwist Bioscience (TWST) Upgraded to Buy: Here's What You Should KnowTwist Bioscience (TWST) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
LUND, SE / ACCESS Newswire / February 6, 2025 / Alligator Bioscience (STO:ATORX) FDA feedback validates the clinical ...
BlueArc Biosciences has been a winner in all three phases so far of the LymeX Innovation Accelerator competition as it works ...
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Skye Bioscience (SKYE – Research Report), Eton ...
Avanzanite Bioscience B.V., a pioneering commercial-stage specialty pharmaceutical company advancing life-changing medicines ...
Research analysts at William Blair issued their Q2 2026 earnings per share (EPS) estimates for Twist Bioscience in a report ...
Skye Bioscience, Inc.’s SKYE share price has surged by 27.04%, which has investors questioning if this is right time to sell.
SAN DIEGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) ("Skye”), a clinical-stage ...
SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Monday reported a loss of $31.6 million in its fiscal first quarter. The South San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results